Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · IEX Real-Time Price · USD
3.110
0.00 (0.00%)
Jul 22, 2024, 10:03 AM EDT - Market open
Athira Pharma Employees
As of December 31, 2023, Athira Pharma had 67 total employees, including 65 full-time and 2 part-time employees. The number of employees increased by 3 or 4.69% compared to the previous year.
Employees
67
Change (1Y)
3
Growth (1Y)
4.69%
Revenue / Employee
n/a
Profits / Employee
-$1,734,164
Market Cap
118.82M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 67 | 3 | 4.69% |
Dec 31, 2022 | 64 | 29 | 82.86% |
Dec 31, 2021 | 35 | 13 | 59.09% |
Dec 31, 2020 | 22 | - | - |
Related Stocks
Company Name | Employees |
---|---|
American Well | 1,104 |
Agenus | 389 |
Akoya Biosciences | 330 |
Seer, Inc. | 147 |
KORU Medical Systems | 82 |
Immunic | 77 |
Werewolf Therapeutics | 47 |
Relmada Therapeutics | 20 |
ATHA News
- 5 weeks ago - Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer's Disease Patients - GlobeNewsWire
- 6 weeks ago - Glancy Prongay & Murray LLP and Labaton Keller Sucharow LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of the Publicly Traded Common Stock of Athira Pharma, Inc. - (NASDAQ: ATHA) - PRNewsWire
- 7 weeks ago - Athira Pharma to Participate in Upcoming June Conferences - GlobeNewsWire
- 2 months ago - Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action - GlobeNewsWire
- 2 months ago - Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates - GlobeNewsWire
- 2 months ago - Athira Pharma to Participate in Upcoming May Conferences - GlobeNewsWire
- 3 months ago - Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer - GlobeNewsWire
- 3 months ago - Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer's Disease - GlobeNewsWire